<DOC>
	<DOCNO>NCT01682694</DOCNO>
	<brief_summary>A common start dose glucosamine chondroitin reduce inflammation reflect reduction serum C-reactive protein .</brief_summary>
	<brief_title>Glucosamine Chondroitin Effects</brief_title>
	<detailed_description>Use glucosamine chondroitin associate reduced cancer overall mortality . The aim study determine whether common start dose glucosamine chondroitin ( 1500 mg/d + 1200 mg/d , respectively ) reduce systemic inflammation reflect reduction high sensitivity C-reactive protein .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>Healthy Overweight ( body mass index kg/m2 ( BMI ) 25 32.5 ) Nonsmoking men woman Aged 2055y Chronic medical illness , history gastrointestinal , hepatic , renal disorder , inflammatory condition ( include autoimmune inflammatory disease ) Pregnancy lactation Currently weightloss diet BMI ( body mass index ) &lt; 25 &gt; 30 Alcohol intake great 2 drinks/day Current use prescription overthecounter medication , ( Excluding oral contraceptive hormonesecreting IUDs ) , include use aspirin NSAIDs 2 day per week Abnormal renal , liver metabolic test Inability swallow pill Known allergy shellfish Not willing take pill make shellfish animal source Intention relocate study area within next 4 month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>